Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Intangibles (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Change in Intangibles for 2 consecutive years, with $3.5 million as the latest value for Q1 2025.

  • On a quarterly basis, Change in Intangibles changed N/A to $3.5 million in Q1 2025 year-over-year; TTM through Dec 2025 was $3.5 million, a 79.53% decrease, with the full-year FY2025 number at $3.5 million, down 79.53% from a year prior.
  • Change in Intangibles was $3.5 million for Q1 2025 at Day One Biopharmaceuticals, down from $17.1 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $17.1 million in Q2 2024 to a low of $3.5 million in Q1 2025.